Cargando…
P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy
MicroRNA-34 (miR-34) is directly regulated by p53, and its potential tumor suppressive roles have been studied extensively. As a p53-induced microRNA, miR-34 functions as a tumor suppressor by playing a role in cell cycle arrest, apoptosis and metabolic regulation. Among these p53/miR-34 associated...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035797/ https://www.ncbi.nlm.nih.gov/pubmed/24884974 http://dx.doi.org/10.1186/1476-4598-13-115 |
_version_ | 1782318104083169280 |
---|---|
author | Zhang, Ding-Guo Zheng, Jun-Nian Pei, Dong-Sheng |
author_facet | Zhang, Ding-Guo Zheng, Jun-Nian Pei, Dong-Sheng |
author_sort | Zhang, Ding-Guo |
collection | PubMed |
description | MicroRNA-34 (miR-34) is directly regulated by p53, and its potential tumor suppressive roles have been studied extensively. As a p53-induced microRNA, miR-34 functions as a tumor suppressor by playing a role in cell cycle arrest, apoptosis and metabolic regulation. Among these p53/miR-34 associated processes, apoptosis and cell cycle arrest are known as essential for p53/miR-34-mediated tumor suppression. P53-mediated metabolic processes have been shown to play pivotal roles in cancer cell biology. Recent studies have also identified several miR-34 targets involved in p53/miR-34-induced metabolic regulation. However, correlations among these metabolic targets remain to be fully elucidated. In this review, we summarize the current progress in the field of metabolic regulation by the p53/miR-34 axis and propose future directions for the development of metabolic approaches in anticancer therapy. |
format | Online Article Text |
id | pubmed-4035797 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40357972014-05-29 P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy Zhang, Ding-Guo Zheng, Jun-Nian Pei, Dong-Sheng Mol Cancer Review MicroRNA-34 (miR-34) is directly regulated by p53, and its potential tumor suppressive roles have been studied extensively. As a p53-induced microRNA, miR-34 functions as a tumor suppressor by playing a role in cell cycle arrest, apoptosis and metabolic regulation. Among these p53/miR-34 associated processes, apoptosis and cell cycle arrest are known as essential for p53/miR-34-mediated tumor suppression. P53-mediated metabolic processes have been shown to play pivotal roles in cancer cell biology. Recent studies have also identified several miR-34 targets involved in p53/miR-34-induced metabolic regulation. However, correlations among these metabolic targets remain to be fully elucidated. In this review, we summarize the current progress in the field of metabolic regulation by the p53/miR-34 axis and propose future directions for the development of metabolic approaches in anticancer therapy. BioMed Central 2014-05-21 /pmc/articles/PMC4035797/ /pubmed/24884974 http://dx.doi.org/10.1186/1476-4598-13-115 Text en Copyright © 2014 Zhang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Zhang, Ding-Guo Zheng, Jun-Nian Pei, Dong-Sheng P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy |
title | P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy |
title_full | P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy |
title_fullStr | P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy |
title_full_unstemmed | P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy |
title_short | P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy |
title_sort | p53/microrna-34-induced metabolic regulation: new opportunities in anticancer therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035797/ https://www.ncbi.nlm.nih.gov/pubmed/24884974 http://dx.doi.org/10.1186/1476-4598-13-115 |
work_keys_str_mv | AT zhangdingguo p53microrna34inducedmetabolicregulationnewopportunitiesinanticancertherapy AT zhengjunnian p53microrna34inducedmetabolicregulationnewopportunitiesinanticancertherapy AT peidongsheng p53microrna34inducedmetabolicregulationnewopportunitiesinanticancertherapy |